Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20876454 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
Conditions: Multiple Myeloma;   Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: lenalidomide;   Other: placebo

Indicates status has not been verified in more than two years